THE LONG-TERM IMPACT OF BEDAQUILINE-CONTAINING REGIMENS ON COST BURDEN OF DRUG-RESISTANT TUBERCULOSIS IN INDIA

被引：0
|
作者：
Agnarson, M. A. [1 ]
Potluri, R. [2 ]
Bhandari, H. [3 ]
Dhir, A. [4 ]
Kumar, A. [3 ]
Gupta, V [5 ]
Raute, L. [5 ]
Shah, N. [5 ]
Kambili, C. [6 ]
Metz, L. [1 ]
机构：
[1] Johnson & Johnson, New Brunswick, NJ USA
[2] SmartAnalyst Inc, New York, NY USA
[3] SmartAnalyst India Pvt Ltd, Gurgaon, India
[4] SmartAnalyst India Pvt Ltd, Gurgaon, HR, India
[5] Janssen India, Mumbai, Maharashtra, India
[6] Johnson & Johnson, South Raritan, NJ USA
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PIN48
引用
收藏
页码：S648 / S648
页数：1
相关论文
共 50 条
  • [31] Insignificant difference in culture conversion between bedaquiline-containing and bedaquiline-free all-oral short regimens for multidrug-resistant tuberculosis
    Fu, Liang
    Weng, Taoping
    Sun, Feng
    Zhang, Peize
    Li, Hui
    Li, Yang
    Yang, Qianting
    Cai, Yi
    Zhang, Xilin
    Liang, Hancheng
    Chen, Xinchun
    Wang, Zhaoqin
    Liu, Lei
    Zhang, Wenhong
    Deng, Guofang
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2021, 111 : 138 - 147
  • [32] Frequent acquisition of bedaquiline resistance by epidemic extensively drug-resistant Mycobacterium tuberculosis strains in Russia during long-term treatment
    Mokrousov, Igor
    Akhmedova, Gulnora
    Molchanov, Vladimir
    Fundovnaya, Elena
    Kozlova, Elena
    Ostankova, Yulia
    Semenov, Alexander
    Maslennikova, Natalia
    Leontev, Dmitrii
    Zhuravlev, Viacheslav
    Turkin, Eugeni
    Vyazovaya, Anna
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2021, 27 (03) : 478 - 480
  • [33] Initial experience of bedaquiline use in a series of drug-resistant tuberculosis patients from India
    Udwadia, Z. F.
    Amale, R. A.
    Mullerpattan, J. B.
    [J]. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2014, 18 (11) : 1315 - 1318
  • [34] The use of bedaquiline in regimens to treat drug-resistant and drug-susceptible tuberculosis: a perspective from tuberculosis-affected communities
    Mingote, Laia Ruiz
    Namutamba, Dorothy
    Apina, Francis
    Barnabas, Nomampondo
    Contreras, Carmen
    Elnour, Taharqa
    Frick, Mike Watson
    Lee, Cynthia
    Seaworth, Barbara
    Shelly, Debra
    Skipper, Natalie
    dos Santos Filho, Ezio Tavora
    [J]. LANCET, 2015, 385 (9966): : 477 - 479
  • [35] Modeling the impact of bedaquiline treatment strategies on the multidrug-resistant tuberculosis burden in India
    Mehra, M.
    Kambili, C.
    Potluri, R.
    Rhines, A.
    Singh, V.
    Thomas, A.
    [J]. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2017, 21 (08) : 902 - 909
  • [36] Protocol for a systematic review of long-term physical sequelae and financial burden of multidrug-resistant and extensively drug-resistant tuberculosis
    Akalu, Temesgen Yihunie
    Clements, Archie C. A.
    Baraki, Adhanom Gebreegziabher
    Alene, Kefyalew Addis
    [J]. PLOS ONE, 2023, 18 (05):
  • [37] Bedaquiline-containing antituberculous regime-induced cutaneous adverse drug reactions: a 1-year prospective study from a nodal drug-resistant tuberculosis centre
    Pawar, M.
    Zawar, V.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2020, 183 : 73 - 74
  • [38] Long-term safety and tolerability of delamanid-containing regimens in multidrug-resistant and extensively drug-resistant tuberculosis patients in a specialised treatment centre in Berlin, Germany
    Haecker, Brit
    Schoenfeld, Nicolas
    Krieger, David
    Otto-Knapp, Ralf
    Hittel, Norbert
    Pflugmacher, Patricia
    Bauer, Torsten
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2020, 56 (06)
  • [39] Bedaquiline containing regimens for the treatment of multi- and extensively drug-resistant tuberculosis at the programmatic level in Belarus. Prospective cohort study
    Skrahina, Alena
    Hurevich, Henadz
    Setkina, Sviatlana
    Grankov, Viatcheslav
    Solodovnikova, Varvara
    Viatushka, Dzmitri
    Kralko, Victoria
    Klimuk, Dzmitry
    Dara, Masoud
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [40] Treatment Outcomes and Long-term Survival in Patients with Extensively Drug-resistant Tuberculosis
    Kim, Doh Hyung
    Kim, Hee Jin
    Park, Seung-Kyu
    Kong, Suck-Jun
    Kim, Young Sam
    Kim, Tae-Hyung
    Kim, Eun Kyung
    Lees, Ki Man
    Lee, Sung Soon
    Park, Jae Seuk
    Koh, Won-Jung
    Lee, Chang-Hoon
    Kim, Ji Yeon
    Shim, Tae Sun
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2008, 178 (10) : 1075 - 1082
12345